Giuseppina Ortu

Dr. Giuseppina Ortu

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
PCPaul Corstjens
Paul Corstjens
CDClaudia J. de Dood
Claudia J. de Dood
SKStefanie Knopp
Stefanie Knopp
MCMichelle N. Clements
Michelle N. Clements
GOGiuseppina Ortu
Giuseppina Ortu
GDGovert Jan van Dam
Govert Jan van Dam
The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) was funded in 2008 to conduct research that would support country schistosomiasis control programs. As schistosomiasis prevalence decreases in many places and elimination is increasingly within reach, a sensitive and specific test to detect infection with Schistosoma mansoni and Schistosoma haematobium has become a pressing need. After obtaining broad input, SCORE supported Leiden University Medical Center (LUMC) to modify the serum-based antigen assay for use with urine, simplify the assay, and improve its sensitivity. The urine assay eventually contributed to several of the larger SCORE studies. For example, in Zanzibar, we demonstrated that urine filtration, the standard parasite egg detection diagnostic test for S. haematobium, greatly underestimated prevalence in low-prevalence settings. In Burundi and Rwanda, the circulating anodic antigen (CAA) assay provided critical information about the limitations of the stool-based Kato–Katz parasite egg-detection assay for S. mansoni in low-prevalence settings. Other SCORE-supported CAA work demonstrated that frozen, banked urine specimens yielded similar results to fresh ones; pooling of specimens may be a useful, cost-effective approach for surveillance in some settings; and the assay can be performed in local laboratories equipped with adequate centrifuge capacity. These improvements in the assay continue to be of use to researchers around the world. However, additional work will be needed if widespread dissemination of the CAA assay is to occur, for example, by building capacity in places besides LUMC and commercialization of the assay. Here, we review the evolution of the CAA assay format during the SCORE period with emphasis on urine-based applications.

1 May 2001 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
TBThomas A Bonasera
Thomas A Bonasera
GOGiuseppina Ortu
Giuseppina Ortu
YRYulia Rozen
Yulia Rozen
RKRoman Krais
Roman Krais
NFNanette M.T Freedman
Nanette M.T Freedman
EMEyal Mishani
Eyal Mishani

27 September 2017 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
GOGiuseppina Ortu
Giuseppina Ortu
OWOliver Williams
Oliver Williams
Remarkable progress has been made in the fight against neglected tropical diseases, but new challenges have emerged. Innovative diagnostics, better drugs and new insecticides are often identified as the priority; however, access to these new tools may not be sufficient to achieve and sustain disease elimination, if certain challenges and priorities are not considered. The authors summarise key operational challenges, and based on these, identify two major priorities: strengthening the capacity of the primary health care health system in correctly diagnosing and managing neglected tropical diseases; and establishing an effective disease surveillance process. Five steps are proposed as concrete actions to build an effective primary health care service for neglected tropical diseases, and a health management information system capable of accurately reporting these diseases. Community engagement and formalization of community health workers role are proposed as essential components of these steps. Shift of financial support from disease oriented programmes to disease integrated interventions, improved access to international guidelines for primary health care staff, and availability of donated drugs in health care structures are also suggested as key elements of the proposed process. The authors conclude that failure to address these priorities now may lead to further challenges on the long path towards neglected tropical disease elimination and beyond.

12 December 2019 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
AWAlexandra Wharton-Smith
Alexandra Wharton-Smith
CRChristian Rassi
Christian Rassi
EBEsey Batisso
Esey Batisso
GOGiuseppina Ortu
Giuseppina Ortu
RKRebecca King
Rebecca King
DGDawit Getachew
Dawit Getachew
Despite known gender-specific differences in terms of prevalence, transmission and exposure to neglected tropical diseases (NTDs), there is limited discussion of the influence of gender in NTD programmes and interventions. There is a paucity of research on how gender interacts with NTD service provision and uptake. This study, part of broader implementation research in Ethiopia, applied a gender lens to health seeking for five NTDs: lymphatic filariasis, podoconiosis, schistosomiasis, soil-transmitted helminth infection and trachoma. The study was conducted in a district of the Southern Nations, Nationalities, and Peoples' Region of Ethiopia where the five NTDs are prevalent. A qualitative methodology was adopted to explore participants’ perspectives and experiences. Data generation methods included 20 interviews and four focus group discussions. Community members, volunteer Health Development Army leaders, Health Extension Workers and a range of health workers at the health post, health centre and hospital level (n = 59) were purposively sampled. Interviews and focus group discussions were audio recorded, transcribed verbatim into English then analysed through open coding, drawing on constant comparative methods. Gender related factors affected care seeking for NTDs and were described as reasons for not seeking care, delayed care seeking and treating NTDs with natural remedies. Women faced additional challenges in seeking health care due to gender inequalities and power dynamics in their domestic partnerships. Participants recommended raising community awareness about NTDs, however this remains problematic due to gender and social norms around appropriate discourse with members of the opposite gender. The findings from this study provide crucial insights into how gender interacts with accessing health services, at different levels of the health system. If we are committed to leaving no one behind and achieving universal health coverage, it is essential to address gender disparities to access and utilisation of interventions delivered by national NTD programmes. This study provides insights into how gender influences peoples’ access to health services for neglected tropical diseases (NTDs). There is considerable evidence to show that women and girls suffer a greater NTD burden due to their higher levels of poverty, lower education and social status. The psychological and social consequences of NTDs also tend to be worse for women. There is an urgent need to integrate NTDs into basic healthcare services, yet there is little evidence that can support a gender-based approach of how best to do so. This study addresses that gap by exploring how gender affects health seeking behaviour for NTDs in Ethiopia through a series of focus group discussions and interviews with community members and health service providers. The findings provide new insights into why women might not seek care or delay care seeking. In particular, there are reservations about disclosing diseases that affect “hidden” body parts, for example in the case of schistosomiasis, a parasitic infection that can affect the urogenital system. Men, on the other hand, may delay seeking care if they are affected by hydrocele, scrotal swelling that can be caused by lymphatic filariasis. There is therefore a need to adopt a gendered approach to NTD health service delivery.

23 February 2018 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
MCMichelle N. Clements
Michelle N. Clements
PCPaul Corstjens
Paul Corstjens
SBSue Binder
Sue Binder
CCCarl H. Campbell
Carl H. Campbell
CDClaudia J. de Dood
Claudia J. de Dood
GDGovert Jan van Dam
Govert Jan van Dam
Kato-Katz examination of stool smears is the field-standard method for detecting Schistosoma mansoni infection. However, Kato-Katz misses many active infections, especially of light intensity. Point-of-care circulating cathodic antigen (CCA) is an alternative field diagnostic that is more sensitive than Kato-Katz when intensity is low, but interpretation of CCA-trace results is unclear. To evaluate trace results, we tested urine and stool specimens from 398 pupils from eight schools in Burundi using four approaches: two in Burundi and two in a laboratory in Leiden, the Netherlands. In Burundi, we used Kato-Katz and point-of-care CCA (CCAB). In Leiden, we repeated the CCA (CCAL) and also used Up-Converting Phosphor Circulating Anodic Antigen (CAA). We applied Bayesian latent class analyses (LCA), first considering CCA traces as negative and then as positive. We used the LCA output to estimate validity of the prevalence estimates of each test in comparison to the population-level infection prevalence and estimated the proportion of trace results that were likely true positives. Kato-Katz yielded the lowest prevalence (6.8%), and CCAB with trace considered positive yielded the highest (53.5%). There were many more trace results recorded by CCA in Burundi (32.4%) than in Leiden (2.3%). Estimated prevalence with CAA was 46.5%. LCA indicated that Kato-Katz had the lowest sensitivity: 15.9% [Bayesian Credible Interval (BCI): 9.2–23.5%] with CCA-trace considered negative and 15.0% with trace as positive (BCI: 9.6–21.4%), implying that Kato-Katz missed approximately 85% of infections. CCAB underestimated disease prevalence when trace was considered negative and overestimated disease prevalence when trace was considered positive, by approximately 12 percentage points each way, and CAA overestimated prevalence in both models. Our results suggest that approximately 52.2% (BCI: 37.8–5.8%) of the CCAB trace readings were true infections. Whether measured in the laboratory or the field, CCA outperformed Kato-Katz at the low infection intensities in Burundi. CCA with trace as negative likely missed many infections, whereas CCA with trace as positive overestimated prevalence. In the absence of a field-friendly gold standard diagnostic, the use of a variety of diagnostics with differing properties will become increasingly important as programs move towards elimination of schistosomiasis. It is clear that CCA is a valuable tool for the detection and mapping of S. mansoni infection in the field and CAA may be a valuable field tool in the future.

29 August 2002 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
GOGiuseppina Ortu
Giuseppina Ortu
IBIris Ben‐David
Iris Ben‐David
YRYulia Rozen
Yulia Rozen
NFNanette M.T. Freedman
Nanette M.T. Freedman
RCRoland Chisin
Roland Chisin
EMEyal Mishani
Eyal Mishani
Radiosynthesis of ML03 (N‐{4‐[(4,5‐dichloro‐2‐fluorophenyl)amino]quinazolin‐6‐yl}acrylamide), an irreversible EGFr‐TK inhibitor, was developed. Its in vitro and in vivo properties, its potential as PET biomarker in cancer and the feasibility of this type of compounds to be used as anticancer drug agents were evaluated. The compound was labeled with carbon‐11 at the acryloyl amide group, via automated method with high yield, chemical and radiochemical purities. ELISA carried out with A431 lysate showed high potency of ML03 with an apparent IC50 of 0.037 nM. The irreversible binding nature of ML03 was studied and 97.5% EGFr‐TK autophosphorylation inhibition was observed in intact A431 cells 8 hr post incubation with the inhibitor. Specific binding (67%) of [11C]ML03 was obtained in cells. An A431 tumor‐bearing rat model was developed and the validity of the model was tested. In biodistribution studies carried out with tumor‐bearing rats, moderate uptake was observed in tumor and high uptake in liver, kidney and intestine. In metabolic studies, fast degradation of [11C]ML03 was observed in liver and blood indicating a short half‐life of the compound in the body. PET scan with tumor‐bearing rats confirmed the results obtained in the ex vivo biodistribution studies. Although in vitro experiments may indicate efficacy of ML03, non‐specific binding, ligand delivery and degradation in vivo make ML03 ineffective as PET bioprobe. Derivatives of ML03 with lower metabolic clearance rate and higher bioavailability should be synthesized and their potential as anticancer drugs and PET bioprobes evaluated.